BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20699648)

  • 21. Emerging Roles of Calreticulin in Cancer: Implications for Therapy.
    Venkateswaran K; Verma A; Bhatt AN; Shrivastava A; Manda K; Raj HG; Prasad A; Len C; Parmar VS; Dwarakanath BS
    Curr Protein Pept Sci; 2018 Feb; 19(4):344-357. PubMed ID: 28079009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes.
    Schcolnik-Cabrera A; Oldak B; Juárez M; Cruz-Rivera M; Flisser A; Mendlovic F
    Apoptosis; 2019 Apr; 24(3-4):245-255. PubMed ID: 30929105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calreticulin as a marker and therapeutic target for cancer.
    Zhang M; Xiao J; Liu J; Bai X; Zeng X; Zhang Z; Liu F
    Clin Exp Med; 2023 Sep; 23(5):1393-1404. PubMed ID: 36335525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients.
    Kielbik M; Szulc-Kielbik I; Klink M
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the interaction between lysyl-tRNA synthetase and laminin receptor by NMR.
    Cho HY; Ul Mushtaq A; Lee JY; Kim DG; Seok MS; Jang M; Han BW; Kim S; Jeon YH
    FEBS Lett; 2014 Aug; 588(17):2851-8. PubMed ID: 24983501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia.
    Wemeau M; Kepp O; Tesnière A; Panaretakis T; Flament C; De Botton S; Zitvogel L; Kroemer G; Chaput N
    Cell Death Dis; 2010 Dec; 1(12):e104. PubMed ID: 21368877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active site of lysyl-tRNA synthetase: structural studies of the adenylation reaction.
    Desogus G; Todone F; Brick P; Onesti S
    Biochemistry; 2000 Jul; 39(29):8418-25. PubMed ID: 10913247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function of membranous lysyl-tRNA synthetase and its implication for tumorigenesis.
    Young HJ; Lee JW; Kim S
    Biochim Biophys Acta; 2016 Dec; 1864(12):1707-1713. PubMed ID: 27663887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin.
    Ling S; Pi X; Holoshitz J
    J Immunol; 2007 Nov; 179(9):6359-67. PubMed ID: 17947714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calreticulin regulated intrinsic apoptosis through mitochondria-dependent and independent pathways mediated by ER stress in arsenite exposed HT-22 cells.
    Wang X; Liu X; Chen Y; Wang H; Zhang R; Zhang Q; Wei Y; Shi S; Li X
    Chemosphere; 2020 Jul; 251():126466. PubMed ID: 32443253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic clustering of tRNA-specific adenosine deaminase ADAT1 and two tRNA synthetases.
    Maas S; Kim YG; Rich A
    Mamm Genome; 2001 May; 12(5):387-93. PubMed ID: 11331948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The crystal structure of the lysyl-tRNA synthetase (LysU) from Escherichia coli.
    Onesti S; Miller AD; Brick P
    Structure; 1995 Feb; 3(2):163-76. PubMed ID: 7735833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of Entamoeba histolytica lysyl-tRNA synthetase reveal conformational changes upon lysine binding and a specific helix bundle domain.
    Bonnefond L; Castro de Moura M; Ribas de Pouplana L; Nureki O
    FEBS Lett; 2014 Nov; 588(23):4478-86. PubMed ID: 25448989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional convergence of two lysyl-tRNA synthetases with unrelated topologies.
    Terada T; Nureki O; Ishitani R; Ambrogelly A; Ibba M; Söll D; Yokoyama S
    Nat Struct Biol; 2002 Apr; 9(4):257-62. PubMed ID: 11887185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral subversion of immunogenic cell death.
    Kepp O; Senovilla L; Galluzzi L; Panaretakis T; Tesniere A; Schlemmer F; Madeo F; Zitvogel L; Kroemer G
    Cell Cycle; 2009 Mar; 8(6):860-9. PubMed ID: 19221507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
    Yang PM; Hsieh YY; Du JL; Yen SC; Hung CF
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface-exposed calreticulin in the interaction between dying cells and phagocytes.
    Martins I; Kepp O; Galluzzi L; Senovilla L; Schlemmer F; Adjemian S; Menger L; Michaud M; Zitvogel L; Kroemer G
    Ann N Y Acad Sci; 2010 Oct; 1209():77-82. PubMed ID: 20958319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase C is involved in the regulation of several calreticulin posttranslational modifications.
    Cristina Castañeda-Patlán M; Razo-Paredes R; Carrisoza-Gaytán R; González-Mariscal L; Robles-Flores M
    Int J Biochem Cell Biol; 2010 Jan; 42(1):120-31. PubMed ID: 19800981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure.
    Molinari R; D'Eliseo D; Manzi L; Zolla L; Velotti F; Merendino N
    Cancer Immunol Immunother; 2011 Oct; 60(10):1503-7. PubMed ID: 21779875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1H, 13C and 15N resonance assignment of the anticodon binding domain of human lysyl aminoacyl tRNA synthetase.
    Liu S; Howell M; Melby J; Tsang P
    Biomol NMR Assign; 2012 Oct; 6(2):173-6. PubMed ID: 22105307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.